HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE

CLADRIBINE

Cladribine is a purine nucleoside analogue that acts as an antimetabolite, a prodrug that is activated by phosphorylation and transformed to cladribine triphosphate or Cd-ATP (active metabolite). Cd-ATP suppresses ribonucleotide reductase and binds to DNA strands, disrupting repair and DNA synthesis. Its method of action in the therapy of multiple sclerosis is unknown; however, it is suspected to entail cytotoxic effects on B and T cells through DNA synthesis impairment, resulting in lymphocyte depletion.

Use this medication precisely as recommended by your physician. Follow the prescription of your doctor carefully.

The medication dose your physician has given is based on your condition, other medications or food supplements you may take, and your reaction to treatment. To diminish your risks for adverse effects, don’t increase your dosage, take it regularly, or take it as instructed by your physician. Adverse events may still happen even at usual prescription dosages.

If your physician requests you to use this drug consistently, use it regularly to get the most benefits from it. To make you remember it better, take it at a fixed time every day.

Your doctor may need to modify your dosages to ease your symptoms or if you develop adverse reactions.

If you have any inquiries with regards to information, ask your physician or pharmacist.

Cladribine is used in the following conditions:

  • Hairy cell leukemia
  • Waldenstrom’s macroglobulinemia
  • B cell chronic lymphocytic leukemia
  • Relapsing forms of multiple sclerosis

This medicine may be recommended for different uses. Approach your physician or pharmacist for more information.

Do not use Cladribine in people with the following conditions:

  • Tuberculosis
  • Active malignancy
  • Immunocompromised patients
  • HIV infection
  • Hepatitis
  • Lactation
  • (Child-Pugh score >6) impairment (SC)
  • Renal impairment (oral/SC) ranging from moderate to severe 
  • Pregnancy 
  • Moderate to serious hepatic
  • Co-administration with live or live-attenuated vaccines during treatment
  • Concurrent immunosuppressive or myelosuppressive treatment (oral/SC)
  • Men and women of reproductive potential who do not intend to utilize efficient contraception throughout dosing and for 6 months after the final dosage in each treatment course (oral)

Cladribine may have the following side effects:

  • Lymphopenia
  • Neutropenia
  • Increased risk of malignancy
  • Herpes zoster
  • Prolonged immunosuppression
  • Fever
  • Acidosis
  • Anuria
  • Anemia
  • Increased serum creatinine
  • hypersensitivity reactions.
  • Serious neurotoxicity, including irreversible paraparesis and quadriparesis (high IV doses)
  • Hemolytic anemia
  • Thrombocytopenia
  • Serious liver injury
  • Febrile neutropenia
  • Pancytopenia
  • Conjunctivitis
  • Nausea
  • Vomiting
  • Myocardial ischemia
  • Tachycardia
  • Heart murmur
  • Abdominal pain
  • Diarrhea
  • Fatigue
  • Chills
  • Asthenia
  • Malaise
  • Flatulence
  • Constipation
  • Injection site reaction
  • Discomfort
  • Peripheral edema
  • Pneumonia
  • Septic shock
  • Crepitations
  • Dermatomal herpes zoster
  • Oral herpes 
  • Bacteremia
  • Localized infection
  • Contusion Decreased neutrophil count (oral)
  • Increased transaminases
  • Bilirubin
  • Decreased appetite
  • Myalgia
  • Arthralgia
  • Muscle weakness
  • Bone pain
  • Arthritis
  • Back pain (oral)
  • Primary hematological malignancies
  • Secondary malignancies
  • Headache
  • Dizziness
  • Insomnia
  • Confusion
  • Anxiety
  • Depression (oral)
  • Renal failure
  • Abnormal breath or chest sounds
  • Cough
  • Phlebitis
  • Purpura
  • Hypotension
  • Hypertension
  • Epistaxis
  • Dyspnoea
  • Rales
  • Pulmonary interstitial infiltrates
  • Upper respiratory tract infection
  • Bronchitis (oral)
  • Rash
  • Ecchymosis
  • Hyperhidrosis
  • Petechiae
  • Cellulitis
  • Alopecia
  • Urticaria
  • Pruritus
  • Erythema
  • Localized exanthema

Potentially Fatal: 

  • Cardiotoxicity, including acute cardiac failure with myocarditis
  • Graft-versus-host disease
  • Severe bacterial, fungal, and viral infections
  • Tumor lysis syndrome
  • Progressive multifocal leukoencephalopathy
  • Subsequent hyperuricemia 

Keep in mind that your physician has recommended this drug since he or she has known that the advantage to you is more noteworthy than the risk of adverse reactions. Many individuals utilizing this medicine don’t have serious side effects. 

A serious allergy to this medication is uncommon. In any case, seek emergency medical help if you see any manifestations of a serious allergic response, including a rash, tingling or swelling particularly of the face or tongue or throat, dizziness or difficulty in breathing.

This is not a complete list of side effects. If you see other effects not recorded above, contact your physician or pharmacist.

Take extra caution in patients with the following medical conditions:

  • Symptom of bone marrow failure or infiltration
  • Hyperuricemia prophylaxis 
  • Patient with active/acute infection
  • Myelosuppressive pre-treatment
  • Patients with prior malignancy or increased risk of malignancy
  • Patients with lymphocytes count 
  • Patients with high tumor burden
  • Renal and hepatic impairment
  • Severe bone marrow impairment 
  • Patients without a history of exposure to varicella-zoster virus (VZV)

Prior to taking this medicine, tell your physician or pharmacist if you are allergic to it or if you have some other hypersensitivities. This drug may contain inert ingredients, which can cause unfavorable side effects or different issues. Talk with your pharmacist for more information.

Interactions

Cladribine may interact with the following medicines:

  • Nimodipine
  • Dilazep
  • Fludarabine
  • Eltrombopag
  • Nifedipine
  • Cilostazol
  • Reserpine
  • Interferon-β. 
  • Carbamazepine
  • Cladribine tab 
  • Sulindac
  • Corticosteroids
  • rifampicin)

Potentially Fatal:

  • Cyclophosphamide
  • Azathioprine
  • Concurrent live or live-attenuated vaccines.
  • Methotrexate
  • Ciclosporin
  • Chronic corticosteroid use

Inform your physician about the drugs you take, including over-the-counter medications, prescribed drugs, supplements and vitamins.

This is not a complete list of drug interactions. Approach your physician or pharmacist for more details.

The effects of certain medications can change if you consume different medications or herbal products simultaneously. This can build your risk for side effects or may cause your drugs not to work effectively. These interactions are conceivable, yet don’t generally happen. Your physician or pharmacist can prevent or oversee interactions by changing how you utilize your prescriptions or by close checking.

While utilizing this drug, don’t start, stop, or change the dose of other medicines you are using without your physician’s advice.

Symptoms of overdose may include the following: 

  • Nausea
  • Vomiting
  • Dose-dependent lymphopenia
  • Diarrhea
  • Acute nephrotoxicity
  • Anemia
  • Thrombocytopenia
  • Severe bone marrow suppression leading to neutropenia
  • Neurotoxicity, including irreversible paraparesis/quadriparesis, Guillain-Barre and Brown-Sequard syndromes (IV/SC)

Seek medical help immediately.

Available Brands:

  • Leustatin DSC
  • Mavenclad

Related Articles

NASEA

Nasea is a medication that contains ondansetron as its active ingredient. Ondansetron is a selective serotonin 5-HT3 receptor antagonist commonly [...]

MAXICAP

Maxicap is a nutritional supplement that combines multivitamins with lysine, an essential amino acid. It is formulated to provide a [...]

MAXEFTIN

Maxeftin is a potent antibiotic medication used to treat a variety of bacterial infections. It belongs to the cephalosporin class [...]